Gao Hanlin 4
4 · Fulgent Genetics, Inc. · Filed Jun 3, 2026
Research Summary
AI-generated summary of this filing
Fulgent Genetics (FLGT) CSO Gao Hanlin Sells 1,688 Shares
What Happened Gao Hanlin, Chief Scientific Officer of Fulgent Genetics (FLGT), sold 1,688 shares on June 2, 2026 in open-market transactions for a total of $30,191. The reported weighted-average sale price was $17.89 per share (individual trades ranged from $17.63 to $18.10). This was a sale (S) reported to satisfy tax withholding obligations tied to RSUs that vested from a grant made on February 25, 2025.
Key Details
- Transaction date: June 2, 2026; Form 4 filed June 3, 2026 (timely filing).
- Shares sold: 1,688; weighted-average price: $17.89; total proceeds: $30,191.
- Price range across multiple trades: $17.63–$18.10 (footnote F2). F2 also notes the filer can provide detailed breakdowns on request.
- Reason for sale: tax withholding to cover taxes on vested restricted stock units from the Feb 25, 2025 grant (footnote F1).
- Shares owned after transaction: not specified in the provided filing.
Context The sale was done to meet tax-withholding obligations on vested RSUs, a common, routine insider transaction that does not necessarily signal a change in sentiment about the company. Purchases generally carry more informational weight for bullish signals; this type of sell-to-cover is typically administrative.
Insider Transaction Report
- Sale
Common Stock
[F1][F2]2026-06-02$17.89/sh−1,688$30,191→ 990,374 total
Footnotes (2)
- [F1]The shares were sold by the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 25, 2025, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2025.
- [F2]The shares were sold in multiple transactions at prices ranging from $17.63 to $18.10, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.